相关实验视频

Updated: May 28, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

在IBD护理中,针对个性化药物管理和治疗优化的跨专业方法

Daniel Fleischmann¹, Benedicta Binder², Muriel Huss²

¹Hospital Pharmacy, University Hospital Regensburg, Regensburg, Germany.

Frontiers in medicine

|February 13, 2025

概括

患有炎症性肠病 (IBD) 的患者经常服用多种药物,增加相互作用风险. 跨学科的方法改善了药物安全性和IBD护理中的患者满意度.

科学领域:

胃肠病学和肝病学
临床药房临床药房
患者安全患者安全

背景情况:

慢性炎症性肠病 (IBD) 经常需要复杂的药物治疗方案,增加药物相互作用的风险.
患者经常通过补充剂和自然疗法疗法自我治疗,进一步复杂化药物安全性和药物坚持.
在常规IBD护理中,对药物坚持和缺乏药物联合监督的低最佳评估是常见的.

研究的目的:

实施跨学科干预措施,以提高IBD患者的药物安全性.
通过全面的药物审查和咨询,提高患者的满意度和药物遵守率.
在IBD门诊环境中识别和减轻与药物相关的潜在风险.

主要方法:

一个由医疗和制药专业人员组成的跨学科团队进行了这项研究.
使用IBD特定的问卷和药物审查进行了全面的调查.
干预涉及后续咨询,讨论治疗问题和药物风险.

主要成果:

干预发现了与药物相关的潜在风险和治疗方面的担忧.
这种方法旨在提高患者对治疗方案的满意度.
该研究的重点是改善药物安全性和持续IBD管理的药物坚持.

结论:

涉及药物审查的跨学科方法可以提高IBD患者的安全性.
解决多药和自我治疗对于有效的IBD管理至关重要.
改善药物联合监督和遵守评估对于患者的治疗结果至关重要.

关键词:

临床医药护理临床医药护理炎症性肠病是一种炎症性肠病.专业间的协作专业间的协作药物管理药物管理患者安全患者安全

更多相关视频

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

相关概念视频

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...